Sage Therapeutics Announces Development Plan for Zuranolone (SAGE-217) Following Breakthrough Therapy Guidance Meeting with the U.S. Food & Drug Administration

https://www.globalbankingandfinance.com/category/news/sage-therapeutics-announces-development-plan-for-zuranolone-sage-217-following-breakthrough-therapy-guidance-meeting-with-the-u-s-food-drug-administration/